rs2020869
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001460.5(FMO2):āc.1476A>Gā(p.Lys492=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.146 in 1,507,422 control chromosomes in the GnomAD database, including 17,180 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.16 ( 2032 hom., cov: 32)
Exomes š: 0.14 ( 15148 hom. )
Consequence
FMO2
NM_001460.5 synonymous
NM_001460.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.564
Genes affected
FMO2 (HGNC:3770): (flavin containing dimethylaniline monoxygenase 2) This gene encodes a flavin-containing monooxygenase family member. It is an NADPH-dependent enzyme that catalyzes the N-oxidation of some primary alkylamines through an N-hydroxylamine intermediate. However, some human populations contain an allele (FMO2*2A) with a premature stop codon, resulting in a protein that is C-terminally-truncated, has no catalytic activity, and is likely degraded rapidly. This gene is found in a cluster with other related family members on chromosome 1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 1-171209013-A-G is Benign according to our data. Variant chr1-171209013-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 769543.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.564 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.234 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FMO2 | NM_001460.5 | c.1476A>G | p.Lys492= | synonymous_variant | 9/9 | ENST00000209929.10 | NP_001451.2 | |
LOC124900413 | XR_007066731.1 | n.366-12075T>C | intron_variant, non_coding_transcript_variant | |||||
LOC105371611 | XR_922278.4 | n.514+38568T>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FMO2 | ENST00000209929.10 | c.1476A>G | p.Lys492= | synonymous_variant | 9/9 | 1 | NM_001460.5 | ENSP00000209929 | P1 | |
ENST00000445290.1 | n.139-9498T>C | intron_variant, non_coding_transcript_variant | 2 | |||||||
ENST00000669750.1 | n.448+38553T>C | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.156 AC: 23768AN: 151998Hom.: 2026 Cov.: 32
GnomAD3 genomes
AF:
AC:
23768
AN:
151998
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.145 AC: 196024AN: 1355306Hom.: 15148 Cov.: 19 AF XY: 0.145 AC XY: 98086AN XY: 675514
GnomAD4 exome
AF:
AC:
196024
AN:
1355306
Hom.:
Cov.:
19
AF XY:
AC XY:
98086
AN XY:
675514
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.156 AC: 23785AN: 152116Hom.: 2032 Cov.: 32 AF XY: 0.159 AC XY: 11829AN XY: 74348
GnomAD4 genome
AF:
AC:
23785
AN:
152116
Hom.:
Cov.:
32
AF XY:
AC XY:
11829
AN XY:
74348
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
601
AN:
3476
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at